Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
Dong-Yan Zhang, Yi-Bang Cheng, Qian-Hui Guo...
https://pubmed.ncbi.nlm.nih.gov/33019798/Actively Recruiting
Led by Xiyuan Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-08-20
100
Participants Needed
5
Research Sites
156 weeks
Total Duration
Researchers are studying the effects of Songling Xuemaikang Capsules SLXMKC on adults aged 35 to 65 with grade 1 essential hypertension. The study aims to evaluate how well SLXMKC works, its impact on blood vessel function and structure, and to explore how it may help manage this level of high blood pressure. This is a randomized, double-blind, placebo-controlled trial sponsored by Xiyuan Hospital of China Academy of Chinese Medical Sciences. Participants are randomly assigned to one of two groups for 12 weeks. One group receives therapeutic lifestyle changes for hypertension plus SLXMKC capsules taken three times daily, while the other group receives the same lifestyle changes plus placebo capsules on the same schedule. Both groups follow lifestyle interventions every day during the study period. During the trial, participants will have their blood pressure and vascular health monitored at the start, 4 weeks, and 12 weeks. Assessments include 24-hour blood pressure measurements, vascular stiffness tests, skin capillary density, and other blood pressure-related indicators. Researchers will also track symptoms, mental health scores, and any progression to more severe hypertension or organ damage. Safety and treatment adherence will be closely monitored throughout the study, which is scheduled to end in December 2027.
CONDITIONS
Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial
A
Anlu Wang, Doctor
Q
Qiyu Liu, Doctor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor
Suzhou Hosptial of Traditional Chinese Medicine
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 weeks
Participants take Songling Xuemaikang Capsules or placebo and follow lifestyle interventions to manage grade 1 hypertension.
1 baseline visit and 2 follow-up visits (Week 4 and Week 12)
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Dong-Yan Zhang, Yi-Bang Cheng, Qian-Hui Guo...
https://pubmed.ncbi.nlm.nih.gov/33019798/Qiyu Liu, Linghua Yu, Zenan Zhang...
https://pubmed.ncbi.nlm.nih.gov/40770317/Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor
Suzhou Hosptial of Traditional Chinese Medicine
Collaborating Sponsor